igf 1 (Novus Biologicals)
Structured Review

Igf 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+igf+1/IGF-I%2FIGF-1+Antibody+(SPM406)/pmc13621939-109-23-24
Average 91 stars, based on 4 article reviews
Images
1) Product Images from "IGF ‐1/ SLC25A33 Maintains Blood‐Labyrinth Barrier Integrity by Suppressing TGF ‐β/Smad2‐Mediated Pericyte Activation in Age‐Related Hearing Loss"
Article Title: IGF ‐1/ SLC25A33 Maintains Blood‐Labyrinth Barrier Integrity by Suppressing TGF ‐β/Smad2‐Mediated Pericyte Activation in Age‐Related Hearing Loss
Journal: Aging Cell
doi: 10.1111/acel.70712
Figure Legend Snippet: Transcriptomic analysis identifies IGF‐1/SLC25A33 dysregulation and TGF‐β pathway activation in aged pericytes, which may be associated with ARHL. (A) Representative click‐evoked ABR waveforms showing a threshold of 30 dB SPL (red trace, left) in a young mouse versus 60 dB SPL (red trace, right) in an aged mouse. (B) Click‐evoked ABR thresholds are significantly elevated in old mice compared to young controls. (C) Frequency‐specific ABR thresholds are markedly increased across all tested frequencies (4–32 kHz) in aged mice. (D) DPOAE thresholds are significantly higher in old mice at F 2 = 17.44 kHz ( n = 6 mice). (E) RNA sequencing of FACS‐purified pericytes from young and aged stria vascularis reveals significant downregulation of Igf1 and Slc25a33 mRNA in aged mice ( n = 6 mice). (F) The most enriched DO terms for the differentially expressed genes when old vs. young. (G) The most enriched GO terms for the downregulated genes when old versus young. (H) The most enriched Reactome terms for the downregulated genes when old versus young. (I) KEGG pathway enrichment analysis highlights the TGF‐β signaling pathway as one of the most differentially activated pathways. (J) Gene–gene interaction network for the downregulated genes when old versus young.
Techniques Used: Analysis, Activation Assay, RNA Sequencing, Purification
Figure Legend Snippet: Downregulation of IGF‐1 and SLC25A33 are confirmed in the aged stria vascularis. In vitro studies reveal IGF‐1 regulates SLC25A33 expression. (A, B) qPCR shows downregulation of Igf1 and Slc25a33 mRNA expression in aged pericytes ( n = 3 mice); (C) Immunofluorescence staining confirms colocalization of IGF‐1 (green), SLC25A33 (red) and PDGFRβ (purple, pericyte marker) in the stria vascularis. Age‐dependent alteration of IGF‐1 and SLC25A33 were markedly occurred in pericytes, as indicated by arrows. (D‐E) Quantitative analysis reveals significant downregulation of both IGF‐1 and SLC25A33 fluorescence intensity in aged mice relative to young controls ( n = 5, five typical sections from five individual mice were analyzed per group). (F) qPCR shows that inhibition of IGF‐1 signaling (via NVP‐AEW541) significantly reduces Slc25a33 mRNA levels. (G) Representative Western blot of SLC25A33 protein expression. (H) Densitometric quantification demonstrates reduced SLC25A33 protein upon IGF‐1 inhibition. Control: HBVPs without treatment; IGF‐1 (−): HBVPs treated with NVP‐AEW541; IGF‐1 (+): Cells treated with recombinant IGF‐1. Data are mean ± SEM; n = 3 mice.
Techniques Used: In Vitro, Expressing, Immunofluorescence, Staining, Marker, Analysis, Fluorescence, Inhibition, Western Blot, Control, Recombinant
Figure Legend Snippet: IGF‐1 upregulation promotes SLC25A33 expression in the stria vascularis of aged mice. (A) Immunofluorescence images show IGF‐1 (green) and SLC25A33 (red) expression in the stria vascularis. (B, C) Quantitative analysis reveals that exogenous IGF‐1 supplementation increases both IGF‐1 and SLC25A33 fluorescence intensity, while IGF‐1 inhibition further reduces their expression ( n = 5, five typical sections from five individual mice were analyzed per group). (D) qPCR confirms exogenous IGF‐1 supplementation upregulates Slc25a33 mRNA levels, whereas IGF‐1 inhibition decreases its expression ( n = 3 mice). Control: wild‐type C57BL/6J mice without treatment; IGF‐1 (−): mice treated with NVP‐AEW541; IGF‐1 (+): mice treated with recombinant IGF‐1. Data are mean ± SEM.
Techniques Used: Expressing, Immunofluorescence, Analysis, Fluorescence, Inhibition, Control, Recombinant
Figure Legend Snippet: Exogenous IGF‐1 rescues blood‐labyrinth barrier integrity and improves hearing function in aged mice. (A) TEM images reveal ultrastructural changes in the stria vascularis. In the IGF‐1‐inhibited group, pericytes exhibit abnormal morphology, loose association with endothelial cells, and widened tight junctions (yellow arrows). These defects are ameliorated by exogenous IGF‐1 administration. (B) Click‐evoked ABR thresholds are significantly elevated in IGF‐1‐suppressed mice but partially rescued by IGF‐1 supplementation. (C–E) At 12 kHz, ABR thresholds are significantly lower in the IGF‐1‐treated group compared to control and suppressed groups, indicating improved auditory sensitivity. (F) Proposed model of IGF‐1/SLC25A33‐mediated regulation of pericyte phenotype and BLB integrity in age‐related hearing loss. Under physiological conditions, pericytes maintain a quiescent state characterized by low α‐SMA and high E‐cadherin expression, contributing to BLB stability. With aging, declining IGF‐1 levels lead to reduced SLC25A33 expression, resulting in mtROS accumulation and activation of the TGF‐β/Smad2 signaling pathway. This drives pericyte transition toward a contractile, pro‐fibrotic phenotype (high α‐SMA, low E‐cadherin), disrupting BLB integrity and promoting cochlear dysfunction. Targeting this axis may offer therapeutic potential for ARHL. Control: wild‐type C57BL/6J mice without treatment; IGF‐1 (−): mice treated with NVP‐AEW541; IGF‐1 (+): mice treated with recombinant IGF‐1. Data are mean ± SEM; n = 6 mice.
Techniques Used: Morphology, Control, Sensitivity, Expressing, Stability, Activation Assay, Recombinant
Related Articles
other:Article Title: Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion Article Snippet: IGF-1 , Flow Cytometry:Article Title: Promoted CD4 + T cell-derived IFN-γ/IL-10 by photobiomodulation therapy modulates neurogenesis to ameliorate cognitive deficits in APP/PS1 and 3xTg-AD mice. Article Snippet: .. The antibodies used for flow cytometry were as follows: BB700 anti-mouse CD4 (BD, 566408); APC anti-mouse IFN-γ (BD, 562018); FITC anti-mouse CD69 (BD, 561929); PE anti-mouse IL-10 (BD, 561060); anti-Tuj1 (Proteintech, 66375-1-lg); anti-Nestin (Proteintech, 19483-1-AP); anti-AMPAR (Proteintech, 11994-1-AP); anti-PSD95 (Proteintech, 20665-1-AP); anti-Iba-1 (CST, 17198); |
